MedPath

Sigma-Tau Research Switzerland SA

🇨🇭Switzerland
Ownership
Private
Employees
-
Market Cap
-
Website

SST0001 (Roneparstat) in Advanced Multiple Myeloma

Phase 1
Completed
Conditions
Multiple Myeloma
Interventions
Drug: SST0001 (Roneparstat)
First Posted Date
2013-01-10
Last Posted Date
2017-10-23
Lead Sponsor
Sigma Tau Research Switzerland SA
Target Recruit Count
19
Registration Number
NCT01764880
Locations
🇩🇪

Manik Chatterjee, Würzburg, Germany

🇮🇱

Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel

🇮🇹

U.O. Ematologia con Trapianto, Dipartimento dell'Emergenza e dei Trapianti di Organi, Bari, Italy

and more 2 locations
© Copyright 2025. All Rights Reserved by MedPath